Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | +0.72% | +3.70% | +19.66% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 30
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Suprachoroidal Space
100.0
%
| 1 | 100.0 % | 8 | 100.0 % | +519.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 8 | 100.0 % | +519.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Rafael V. Andino
CTO | Chief Tech/Sci/R&D Officer | - | 13-01-31 |
Jenny Kobin
IRC | Investor Relations Contact | - | - |
Viral Kansara
PRN | Corporate Officer/Principal | - | 17-12-31 |
General Counsel | - | 16-11-30 | |
Rick McElheny
PRN | Corporate Officer/Principal | - | 16-11-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Benjamin Yerxa
BRD | Director/Board Member | 58 | 22-03-02 |
Director/Board Member | 57 | 11-12-31 | |
Richard Croarkin
BRD | Director/Board Member | 69 | 16-02-28 |
Nancy Hutson
BRD | Director/Board Member | 74 | 20-04-20 |
Clay Thorp
CHM | Chairman | 55 | 11-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,731,139 | 69,151,973 ( 92.53 %) | 0 | 92.53 % |
Company contact information
Clearside Biomedical, Inc.
900 North Point Parkway Suite 200
30005, Alpharetta
+678 270 3631
http://www.clearsidebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.66% | 105M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CLSD Stock
- Company Clearside Biomedical, Inc.